451 related articles for article (PubMed ID: 21573959)
1. Antiangiogenic treatments and mechanisms of action in renal cell carcinoma.
Négrier S; Raymond E
Invest New Drugs; 2012 Aug; 30(4):1791-801. PubMed ID: 21573959
[TBL] [Abstract][Full Text] [Related]
2. Impact of anti-angiogenic treatments on metastatic renal cell carcinoma.
Ainsworth NL; Lee JS; Eisen T
Expert Rev Anticancer Ther; 2009 Dec; 9(12):1793-805. PubMed ID: 19954291
[TBL] [Abstract][Full Text] [Related]
3. Anti-angiogenic targets in the treatment of advanced renal cell carcinoma.
Heng DY; Bukowski RM
Curr Cancer Drug Targets; 2008 Dec; 8(8):676-82. PubMed ID: 19075590
[TBL] [Abstract][Full Text] [Related]
4. Sunitinib, sorafenib and mTOR inhibitors in renal cancer.
Radulovic S; Bjelogrlic SK
J BUON; 2007 Sep; 12 Suppl 1():S151-62. PubMed ID: 17935273
[TBL] [Abstract][Full Text] [Related]
5. Antiangiogenic therapy for advanced renal cell carcinoma: management of treatment-related toxicities.
Cohen RB; Oudard S
Invest New Drugs; 2012 Oct; 30(5):2066-79. PubMed ID: 22327313
[TBL] [Abstract][Full Text] [Related]
6. Optimal management of metastatic renal cell carcinoma: current status.
Escudier B; Albiges L; Sonpavde G
Drugs; 2013 Apr; 73(5):427-38. PubMed ID: 23572408
[TBL] [Abstract][Full Text] [Related]
7. New agents in renal cell carcinoma.
Dabney R; Devine R; Sein N; George B
Target Oncol; 2014 Sep; 9(3):183-93. PubMed ID: 24243495
[TBL] [Abstract][Full Text] [Related]
8. Targeted therapy for advanced renal cell cancer (RCC): a Cochrane systematic review of published randomised trials.
Coppin C; Kollmannsberger C; Le L; Porzsolt F; Wilt TJ
BJU Int; 2011 Nov; 108(10):1556-63. PubMed ID: 21952069
[TBL] [Abstract][Full Text] [Related]
9. Targeted Therapy for Metastatic Renal Cell Carcinoma.
Afriansyah A; Hamid AR; Mochtar CA; Umbas R
Acta Med Indones; 2016 Oct; 48(4):335-347. PubMed ID: 28143997
[TBL] [Abstract][Full Text] [Related]
10. Improvement in survival end points of patients with metastatic renal cell carcinoma through sequential targeted therapy.
Calvo E; Schmidinger M; Heng DY; Grünwald V; Escudier B
Cancer Treat Rev; 2016 Nov; 50():109-117. PubMed ID: 27664394
[TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor-targeted therapies in advanced renal cell carcinoma.
Albiges L; Salem M; Rini B; Escudier B
Hematol Oncol Clin North Am; 2011 Aug; 25(4):813-33. PubMed ID: 21763969
[TBL] [Abstract][Full Text] [Related]
12. Targeted therapies in the treatment of advanced renal cell carcinoma.
Seront E; Machiels JP
Recent Pat Anticancer Drug Discov; 2009 Jun; 4(2):146-56. PubMed ID: 19519537
[TBL] [Abstract][Full Text] [Related]
13. [Renal cell carcinoma].
Tomita Y
Gan To Kagaku Ryoho; 2014 Feb; 41(2):172-7. PubMed ID: 24743196
[TBL] [Abstract][Full Text] [Related]
14. Toxicities of targeted agents in advanced renal cell carcinoma.
Patel P; Srinivas S
Curr Clin Pharmacol; 2011 Aug; 6(3):181-8. PubMed ID: 21827392
[TBL] [Abstract][Full Text] [Related]
15. Emerging antiangiogenics for renal cancer.
Domblides C; Gross-Goupil M; Quivy A; Ravaud A
Expert Opin Emerg Drugs; 2013 Dec; 18(4):495-511. PubMed ID: 24274612
[TBL] [Abstract][Full Text] [Related]
16. Reappraisal of the role of bevacizumab in the therapeutic strategy in advanced renal cell carcinoma.
Guillot A; Levy A; Pacaut C; Collard O; Massard C; Merrouche Y; Magné N
Clin Genitourin Cancer; 2012 Sep; 10(3):147-52. PubMed ID: 22796529
[TBL] [Abstract][Full Text] [Related]
17. Pazopanib for the treatment of renal cancer.
Al-Marrawi MY; Rini B
Expert Opin Pharmacother; 2011 May; 12(7):1171-89. PubMed ID: 21470066
[TBL] [Abstract][Full Text] [Related]
18. A comprehensive overview of targeted therapy in metastatic renal cell carcinoma.
Mihaly Z; Sztupinszki Z; Surowiak P; Gyorffy B
Curr Cancer Drug Targets; 2012 Sep; 12(7):857-72. PubMed ID: 22515521
[TBL] [Abstract][Full Text] [Related]
19. [Medical treatment of renal cell carcinoma].
Guy L; Bay JO; Bastide C; Mahammedi H; Bruyere F; Karsenty G
Prog Urol; 2013 Nov; 23(15):1225-37. PubMed ID: 24183081
[TBL] [Abstract][Full Text] [Related]
20. Novel therapeutics for metastatic renal cell carcinoma.
Hutson TE; Figlin RA
Cancer; 2009 May; 115(10 Suppl):2361-7. PubMed ID: 19402059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]